Biochemists discover how reactive oxygen species affect cisplatin resistance in ovarian cancer cells
Thursday, September 13, 2018 - 09:00
in Health & Medicine
A team of sciences from the RUDN Institute of Medicine has reported how reactive oxygen species (ROSs) affect the resistance of ovarian cancer cells to chemotherapy on the example of cisplatin—an antitumor drug used to treat this type of malignant growth. Practical application of the research results would help improve medical treatment schemes for cancer patients. The article was published in the Materials of FEBS Congress.